These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 18549362)
1. Treatment-refractory migraine: the case for opioid therapy. Rothrock JF Headache; 2008 Jun; 48(6):850-4. PubMed ID: 18549362 [No Abstract] [Full Text] [Related]
2. Refractory headache: classification and nomenclature. Levin M Headache; 2008 Jun; 48(6):783-90. PubMed ID: 18549356 [TBL] [Abstract][Full Text] [Related]
3. Continuous opioid therapy (COT) is rarely advisable for refractory chronic daily headache: limited efficacy, risks, and proposed guidelines. Saper JR; Lake AE Headache; 2008 Jun; 48(6):838-49. PubMed ID: 18549361 [TBL] [Abstract][Full Text] [Related]
4. Outpatient home-based continuous intravenous dihydroergotamine therapy for intractable migraine. Charles JA; von Dohln P Headache; 2010 May; 50(5):852-60. PubMed ID: 20132337 [TBL] [Abstract][Full Text] [Related]
5. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. Schulman EA; Lake AE; Goadsby PJ; Peterlin BL; Siegel SE; Markley HG; Lipton RB Headache; 2008 Jun; 48(6):778-82. PubMed ID: 18484982 [TBL] [Abstract][Full Text] [Related]
6. Toward an epidemiology of refractory migraine: current knowledge and issues for future research. Lipton RB; Bigal ME Headache; 2008 Jun; 48(6):791-8. PubMed ID: 18479422 [TBL] [Abstract][Full Text] [Related]
7. Migraine and its connections in neurology and psychiatry. Roberts AC CNS Spectr; 2003 Sep; 8(9):635; author reply 635. PubMed ID: 15079136 [No Abstract] [Full Text] [Related]
8. A practice guide for continuous opioid therapy for refractory daily headache. Robbins L Headache; 2010 Nov; 50(10):1614. PubMed ID: 20946436 [No Abstract] [Full Text] [Related]
9. Opioid therapy for the treatment of refractory pain in children with juvenile rheumatoid arthritis. Connelly M; Schanberg L Nat Clin Pract Rheumatol; 2006 Dec; 2(12):636-7. PubMed ID: 17133244 [No Abstract] [Full Text] [Related]
12. DIRE: a tool to assess risks of maintaining opioid treatment. Brennan MJ J Pain; 2007 Feb; 8(2):185; author reply 186. PubMed ID: 17280938 [No Abstract] [Full Text] [Related]
13. Reflections and speculations on refractory migraine: why do some patients fail to improve with currently available therapies? Dodick DW Headache; 2008 Jun; 48(6):828-37. PubMed ID: 18549360 [TBL] [Abstract][Full Text] [Related]
14. Migraine headache: a call for humane treatment. Difatta AS J Am Osteopath Assoc; 1987 Sep; 87(9):581-3. PubMed ID: 2889703 [No Abstract] [Full Text] [Related]
15. Pharmaceutics: therapy for intractable pain. Bibb PI Cancer Nurs; 1979 Jun; 2(3):247-8. PubMed ID: 36222 [No Abstract] [Full Text] [Related]
16. Refractory headache: historical perspective, need, and purposes for an operational definition. Schulman EA; Brahin EJ Headache; 2008 Jun; 48(6):770-7. PubMed ID: 18479419 [TBL] [Abstract][Full Text] [Related]
17. [The role of opioids in the treatment of primary headache disorders]. Totzeck A; Gaul C Schmerz; 2014 Apr; 28(2):135-40. PubMed ID: 24500765 [TBL] [Abstract][Full Text] [Related]
18. European pain management discussion forum. Eisenberg E J Pain Palliat Care Pharmacother; 2007; 21(4):39-40. PubMed ID: 18032315 [TBL] [Abstract][Full Text] [Related]
19. [Therapy and prophylaxis of migraine]. Hoffmann J; Reuter U MMW Fortschr Med; 2009 Apr; 151(14):114-7; quiz 118. PubMed ID: 19504851 [No Abstract] [Full Text] [Related]